Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 515-1 (miR-515-1) is a non-coding RNA molecule of the microRNA class involved in post-transcriptional regulation of gene expression. It is processed from primary transcripts into a mature miRNA that becomes part of the RNA-induced silencing complex (RISC), where it binds to target mRNAs with partially complementary sequences, most often resulting in inhibition of translation or degradation of the mRNA. MIR515-1 is linked with disease processes such as ovarian cancer and placenta previa, and generally functions through fine-tuning of cellular gene expression programs related to cell proliferation, differentiation, and immune response. It is not a receptor or enzyme but acts as a non-coding RNA regulator in a wide range of cellular contexts[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 515-1 (miR-515-1).